Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor

Toxicology and Applied Pharmacology

Volumn 163, Issue 2, 2000, Pages 195-202

  Howard, William R ^a   Pospisil, John A ^b   Njolito, Eugenia ^a   Noonan, Daniel J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXMARK INTERNATIONAL INC   (United States)

Author keywords

Androgens; Apoptosis; Asthma; Bile acids; Bronchodilatory; Farnesoid X receptor (FXR); Forskolin; Glucuronosyltransferase; Nuclear receptor; Protein kinase A (PKA); Steroid receptor

Indexed keywords

ANDROSTERONE; CELL NUCLEUS RECEPTOR; CHENODEOXYCHOLIC ACID; DEOXYCHOLIC ACID; ETIOCHOLANOLONE;

ANIMAL CELL; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME INHIBITION; HORMONE ACTION; LIVER TOXICITY; NONHUMAN; TOXICITY TESTING;

ANIMALIA; MAMMALIA;

EID: 0034163857     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8869     Document Type: Article

References (57)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
2. Angelin B., Einarsson K., Leijd B. Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur. J. Clin. Invest. 9:1979;185-190.
3. Angelin B. O., Bjorkhem I., Einarsson K. Effects of clofibrate on some microsomal hydroxylations involved in the formation and metabolism of bile acids in rat liver. Biochem. J. 156:1976;445-448.
4. Arvind P., Papavassiliou E. D., Tsioulias G. J., Duceman B. W., Lovelace C. I., Geng W., Staiano-Coico L., Rigas B. Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci. Mol. Immunol. 31:1994;607-614.
5. Bayerdorffer E., Mannes G. A., Richter W. O., Ochsenkuhn T., Wiebecke B., Kopcke W., Paumgartner G. Increased serum deoxycholic acid levels in men with colorectal adenomas [see comments]. Gastroenterology. 104:1993;145-151.
6. Bjorkhem I. Inborn errors of metabolism with consequences for bile acid biosynthesis. A minireview. Scand. J. Gastroenterol. Suppl. 204:1994;68-72.
7. Bouscarel B., Matsuzaki Y., Le M., Gettys T. W., Fromm H. Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL. Am. J. Physiol. 274:1998;G1151-G1159.
8. Boyer B., Thiery J. P. Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line. J. Cell. Biol. 120:1993;767-776.
9. Brady L. M., Beno D. W., Davis B. H. Bile acid stimulation of early growth response gene and mitogen-activated protein kinase is protein kinase C-dependent. Biochem. J. 316:1996;765-769.
10. Calmus Y., Weill B., Ozier Y., Chereau C., Houssin D., Poupon R. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology. 103:1992;617-621.
11. Chung W. G., Roh H. K., Kim H. M., Cha Y. N. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns. Chem.-Biol. Interact. 113:1998;1-14.
12. Cobb V. J., Williams B. C., Mason J. I., Walker S. W. Forskolin treatment directs steroid production towards the androgen pathway in the NCI-H295R adrenocortical tumour cell line. Endocr. Res. 22:1996;545-550.
13. Earnest D. L., Holubec H., Wali R. K., Jolley C. S., Bissonette M., Bhattacharyya A. K., Roy H., Khare S., Brasitus T. A. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 54:1994;5071-5074.
14. Farrants A. K., Nilsson A., Troen G., Blomhoff R., Pedersen J. I. The effect of retinoids and clofibric acid on the peroxisomal oxidation of palmitic acid and of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid in rat and rabbit hepatocytes. Biochim. Biophys. Acta. 1168:1993;100-107.
15. Faubion W. A., Guicciardi M. E., Miyoshi H., Bronk S. F., Roberts P. J., Svingen P. A., Kaufmann S. H., Gores G. J. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 103:1999;137-145.
16. Feduccia T. D., Scott-Conner C. E., Grogan J. B. Profound suppression of lymphocyte function in early biliary obstruction. Am. J. Med. Sci. 296:1988;39-44.
17. Forman B. M., Goode E., Chen J., Oro A. E., Bradley D. J., Perlmann T., Noonan D. J., Burka L. T., McMorris T., Lamph W. W. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 81:1995;687-693.
18. Garewal H., Bernstein H., Bernstein C., Sampliner R., Payne C. Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: A potential biological marker for cancer risk. Cancer Res. 56:1996;1480-1483.
19. Gianni L., Di Padova F., Zuin M., Podda M. Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: An in vitro study. Gastroenterology. 78:1980;231-235.
20. Hanley K., Jiang Y., Crumrine D., Bass N. M., Appel R., Elias P. M., Williams M. L., Feingold K. R. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J. Clin. Invest. 100:1997;705-712.
21. Henry K., O'Brien M. L., Clevenger W., Jow L., Noonan D. J. Peroxisome proliferator-activated receptor response specificities as defined in yeast and mammalian cell transcription assays. Toxicol. Appl. Pharmacol. 132:1995;317-324.
22. Hirano F., Tanada H., Makino Y., Okamoto K., Hiramoto M., Handa H., Makino I. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis. 17:1996;427-433.
23. Jin C. J., Mackenzie P. I., Miners J. O. The regio- and stereo-selectivity of C19 and C21 hydroxysteroid glucuronidation by UGT2B7 and UGT2B11. Arch. Biochem. Biophys. 341:1997;207-211.
24. Kano M., Shoda J., Irimura T., Ueda T., Iwasaki R., Urasaki T., Kawauchi Y., Asano T., Matsuzaki Y., Tanaka N. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones. Hepatology. 28:1998;302-313.
25. Keane R. M., Gadacz T. R., Munster A. M., Birmingham W., Winchurch R. A. Impairment of human lymphocyte function by bile salts. Surgery. 95:1984;439-443.
26. Lichey I., Friedrich T., Priesnitz M., Biamino G., Usinger P., Huckauf H. Effect of forskolin on methacholine-induced bronchoconstriction in extrinsic asthmatics [letter]. Lancet. 2:1984;167.
27. Mackenzie P. I., Mojarrabi B., Meech R., Hansen A. Steroid UDP glucuronosyltransferases: Characterization and regulation. J. Endocrinol. 150:1996;S79-S86.
28. Magnuson B. A., Bird R. P. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett. 68:1993;15-23.
29. Magnuson B. A., Carr I., Bird R. P. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res. 53:1993;4499-4504.
30. Makishima M., Okamoto A. Y., Repa J. J., Tu H., Learned R. M., Luk A., Hull M. V., Lustig K. D., Mangelsdorf D. J., Shan B. Identification of a nuclear receptor for bile acids [see comments]. Science. 284:1999;1362-1365.
31. Martinez J. D., Stratagoules E. D., LaRue J. M., Powell A. A., Gause P. R., Craven M. T., Payne C. M., Powell M. B., Gerner E. W., Earnest D. L. Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr. Cancer. 31:1998;111-118.
32. McSherry C. K., Cohen B. I., Bokkenheuser V. D., Mosbach E. H., Winter J., Matoba N., Scholes J. Effects of calcium and bile acid feeding on colon tumors in the rat. Cancer Res. 49:1989;6039-6043.
33. Meng L. J., Reyes H., Palma J., Hernandez I., Ribalta J., Sjovall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J. Hepatol. 27:1997;1029-1040.
34. Mukherjee R., Jow L., Noonan D., McDonnell D. P. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J. Steroid Biochem. Mol. Biol. 51:1994;157-166.
35. Nelson D. L., Frazier D. E. Jr., Ericson J. E., Tarr M. J., Mathes L. E. The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats. Immunopharmacol. Immunotoxicol. 14:1992;925-938.
36. O'Brien M. L., Rangwala S. M., Henry K. W., Weinberger C., Crick D. C., Waechter C. J., Feller D. R., Noonan D. J. Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis. Carcinogenesis. 17:1996;185-190.
37. Paolini M., Pozzetti L., Piazza F., Cantelli-Forti G., Roda A. Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes. Hepatology. 30:1999;730-739.
38. Parks D. J., Blanchard S. G., Bledsoe R. K., Chandra G., Consler T. G., Kliewer S. A., Stimmel J. B., Willson T. M., Zavacki A. M., Moore D. D., Lehmann J. M. Bile acids: Natural ligands for an orphan nuclear receptor [see comments]. Science. 284:1999;1365-1368.
39. Radominska A., Little J. M., Lester R., Mackenzie P. I. Bile acid glucuronidation by rat liver microsomes and cDNA-expressed UDP-glucuronosyltransferases. Biochim. Biophys. Acta. 1205:1994;75-82.
40. Rao Y. P., Stravitz R. T., Vlahcevic Z. R., Gurley E. C., Sando J. J., Hylemon P. B. Activation of protein kinase C alpha and delta by bile acids: Correlation with bile acid structure and diacylglycerol formation. J. Lipid Res. 38:1997;2446-2454.
41. Reddy B. S., Simi B., Patel N., Aliaga C., Rao C. V. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Cancer Res. 56:1996;2314-2320.
42. Reddy B. S., Watanabe K., Weisburger J. H., Wynder E. L. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 37:1977;3238-3242.
43. Reddy J. K., Mannaerts G. P. Peroxisomal lipid metabolism. Annu. Rev. Nutr. 14:1994;343-370.
44. Rodrigues C. M., Kren B. T., Steer C. J., Setchell K. D. Formation of delta 22-bile acids in rats is not gender specific and occurs in the peroxisome. J. Lipid Res. 37:1996;540-550.
45. Sidhu J. S., Omiecinski C. J. Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP. J. Pharmacol. Exp. Ther. 276:1996;238-245.
46. Song C. S., Jung M. H., Kim S. C., Hassan T., Roy A. K., Chatterjee B. Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J. Biol. Chem. 273:1998;21856-21866.
47. Stahlberg D., Angelin B., Einarsson K. Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes. J. Lipid Res. 30:1989;953-958.
48. Stahlberg D., Reihner E., Rudling M., Berglund L., Einarsson K., Angelin B. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: Reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology. 21:1995;1025-1030.
49. van den Bosch H., Schutgens R. B., Wanders R. J., Tager J. M. Biochemistry of peroxisomes. Annu. Rev. Biochem. 61:1992;157-197.
50. van Bergmann K., Leiss O. Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia. Eur. J. Clin. Invest. 14:1984;150-154.
51. Wanders R. J., Schutgens R. B., Barth P. G. Peroxisomal disorders: A review. J. Neuropathol. Exp. Neurol. 54:1995;726-739.
52. Wang H., Chen J., Hollister K., Sowers L. C., Forman B. M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3:1999;543-553.
53. Wargovich M. J., Eng V. W., Newmark H. L., Bruce W. R. Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis. 4:1983;1205-1207.
54. Waxman D. J. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. J. Endocrinol. 150:1996;S129-S147.
55. Williams M. L., Hanley K., Elias P. M., Feingold K. R. Ontogeny of the epidermal permeability barrier. J. Invest. Dermatol. Symp. Proc. 3:1998;75-79.
56. Yousif M. H., Thulesius O. Forskolin reverses tachyphylaxis to the bronchodilator effects of salbutamol: An in-vitro study on isolated guinea-pig trachea. J. Pharm. Pharmacol. 51:1999;181-186.
57. Zhou Y. C., Waxman D. J. Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ. Health Perspect. 106:1998;983-988.